Skip to content

Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK

Lynn T. Singer, Derek G. Moore, Meeyoung O. Min, Julia Goodwin, J. Turner, Sarah Fulton, Andrew C. Parrott

Human Psychopharmacology: Clinical and Experimental July 1, 2015 DOI: 10.1002/hup.2459 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Longitudinal study Peer reviewed
Population Infants with prenatal MDMA exposure
Topics MDMA
Citations 16
Key findings Prenatal MDMA exposure may be associated with motor development delays in infancy, with effects appearing dose-dependent.

Abstract

This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, “ecstasy”) on infant development.

Comparable studies

Other observational and cohort studies on MDMA, most cited first.

Study Year Design Participants
Subjective Reports of the Effects of MDMA in a Clinical Setting Individuals who took MDMA in a clinical setting 1986 Observational study
Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users 1998 Observational cohort
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people 2000 Observational
The Psychological and Physiological Effects of MDMA on Normal Volunteers Older, more educated, drug-experienced individuals 1986 Observational cohort
Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits Young people who were regular or novice MDMA users, or non-users 1998 Observational cohort n = 30

Citations in the library

Explore topics